Drug intelligence / Profile preview

ABG+

Development stage
Unknown
Lead developer
Pharmactive Biotech Products
Administration
Oral
01

Overview

ABG+ is a proprietary aged black garlic extract developed as a dietary supplement, primarily for cardiovascular health. The product is derived from whole raw garlic bulbs (Allium sativum) that are aged under controlled conditions to enhance the accumulation of bioactive antioxidant compounds, especially S-allyl cysteine (SAC), polyphenols, flavonoids, and melanoidins. This aging process increases the stability and bioavailability of these compounds compared to fresh garlic. Clinical studies have shown that supplementation with aged black garlic extracts like ABG10+ (a closely related or possibly identical product) can help reduce blood pressure in patients with grade-1 hypertension who are already on antihypertensive medication. The proposed mechanisms include increased nitric oxide production (vasorelaxation), reduced angiotensin-converting enzyme activity, enhanced antioxidant capacity, and lower uric acid levels[4][5].

Brand names
ABG+
Other names
ABG+
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on ABG+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABG+.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call